SRS. Rasoul

S. Rasoul

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


S. Rasoul has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multivessel revascularisation versus infarct-related artery only revascularisation during the index primary PCI in STEMI patients with multivessel disease: a meta-analysis

    by S. Rasoul, V. van Ommen, J. Vainer, M. Ilhan, L. Veenstra, R. Erdem, L.A.W. Ruiters, R. Theunissen, J.C.A. Hoorntje

    There are controversial data regarding infarct-related artery only (IRA-PCI) revascularisation versus multivessel revascularisation (MV-PCI) in ST-elevation myocardial infarction (STEMI) patients with multivessel disease undergoing primary percutaneous coronary intervention (PCI). We performed a meta-analysis comparing outcome in same stage MV-PCI versus IRA-PCI in STEMI patients with multivessel disease.


  • Impact of out-of-hospital cardiac arrest on outcome in STEMI patients treated with primary PCI

    by S. Rasoul, F. Demirel, A. Elvan, J. P. Ottervanger, J. H. E. Dambrink, A. T. M. Gosselink, J. C. A. Hoorntje, A. R. Ramdat Misier, A. W. J. Van 'T Hof

    Purpose: Pre-hospital ventricular arrhythmia is common in the acute phase of ST-elevation myocardial infarction (STEMI). We assessed the prognostic impact of out of hospital cardiac arrest (OHCA) in a non-selected STEMI patient population treated with primary percutaneous coronary intervention (PCI). Methods: Registry database of all individual STEMI patients admitted to our hospital during 2005-2010. Patients with OHCA were identified from the register, and their medical records were reviewed. Results: During the study period 4653 patients were admitted with STEMI. Information regarding OHCA was available in 4640 patients (99.7%). A total of 326 patients (7.0%) had OHCA. Patients with OHCA were younger (60.3±11.8 vs. 64.1±12.9, pConclusion: In a large non-selected STEMI patient population treated with primary PCI, OHCA was associated with higher in-hospital mortality but did not affect the long-term prognosis for those discharged alive.

    • 1 March 2007
      • Vol. 65  (3) , 95-100

    Glucose dysregulation in nondiabetic patients with ST-elevation myocardial infarction: acute and chronic glucose dysregulation in STEMI.

    by S Rasoul, J P Ottervanger, H J G Bilo, J R Timmer, A W J Van 't Hof, J H E Dambrink, L D Dikkeschei, J C A Hoorntje, M J De Boer, F Zijlstra

    Admission hyperglycaemia is associated with an increased risk of mortality after myocardial infarction. Whether long-term glucose dysregulation (assessed by HbA1c) is more important than acute hyperglycaemia is unknown. We evaluated the prognostic value of admission glucose and HbA1c levels in nondiabetic patients with ST-segment elevation acute myocardial infarction (STEMI). In 504 unselected, consecutive patients with STEMI, glucose and HbA1c levels were measured on admission. Glucose was categorised as or= 11.1 mmol/l (n=82). HbA1c levels were categorised as or=6.0% (n=88). Mean follow-up was 1.6+/-0.6 years. Patients with hyperglycaemia on admission were comparable with those with normoglycaemia. However,patients with HbA1c >or=6.0%, as compared with those with HbA1c or=11.1 mmol/l) was 4% and 19% (por=6%) was 5% and 12% (p=0.03). After multivariable analyses, admission glucose (OR 4.91,95% CI 2.03 to 11.9, p< 0.001) but not HbA1c (OR 1.33, 95%CI 0.48 to 3.71, p=0.58) was significantly associated with 30-day mortality. Among 30-day survivors, neither admission glucose nor HbA1c were predictors of long-term mortality. Elevated admission glucose is an important predictor of 30-day outcome after STEMI, while prior long-term glucose dysregulation is a covariate of other high-risk clinical characteristics. Among 30-day survivors, neither admission blood glucose nor HbA1c were predictors of long-term outcome.